子类别 專利 [0/19] 期刊論文 [47/47] 會議論文/會議摘要 [6/8] 邻近社群 其他 [59/61] 夏克山 [77/157] 岳嶽 [29/34] 張仲明 [7/9] 張俊彥 [23/24] 張竣評 [21/38] 徐祖安 [170/241] 李秀珠 [76/108] 李靜琪 [24/28] 林書玉 [21/31] 洪明秀 [33/44] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/105] 童俊維 [25/25] 紀雅惠 [22/28] 翁紹華 [23/43] 莊宏 [1/1] 葉修華 [25/45] 葉燈光 [137/160] 蔣維棠 [43/99] 謝興邦 [180/261] 趙宇生(2002-2013) [120/279] 郭靜娟 [53/59] 鄒倫 [31/71] 陳志豪 [31/70] 陳新(2002-2015) [53/68] 陳炯東 [184/268] 顏婉菁 [6/8] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] 社群统计 近3年内发表的文件:1(1.35%) 含全文笔数:53(71.62%) 文件下载次数统计 下载大于0次:53(100.00%) 下载大于100次:52(98.11%) 全文下载总次数:40857(0.70%) 最后更新时间: 2025-04-28 05:58 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 吡咯烷化合物 Fused bicyclic pyrimidine compounds... Fused bicyclic pyrimidine compounds... Fused bicyclic pyrimidine compounds... 오로라 키나아제 저해제용 접합 2고리 피리미딘 화합물 Fused bicyclic pyrimidine compounds... 作为极光激酶抑制剂的稠合双环嘧啶化合物 作為極光激酶抑制劑的稠合雙環嘧啶化合物 Development of potent and selective... Discovery and development of a nove...

跳至: (选择年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1-25 / 74. (共3页) 1 2 3 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2024-11-26	Development of potent and selective inhibitors of methylenetetrahydrofolate dehydrogenase 2 for targeting acute myeloid leukemia: Sar, structural insights, and biological characterization	Journal of Medicinal Chemistry. 2024 Nov 26;67(23):21106-21125.
2022-02-05	Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design	European Journal of Medicinal Chemistry. 2022 Feb 5;229:Article number 114043.
2021-08-12	Xanthine derivatives reveal an allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2)	Journal of Medicinal Chemistry. 2021 Aug 12;64(15):11288-11301.
2020-02-10	Unique sulfur-aromatic interactions contribute to the binding of potent imidazothiazole indoleamine 2,3-Dioxygenase inhibitors	Journal of Medicinal Chemistry. 2020 Feb 10;63(4):1642-1659.
2019-12	Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia	Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.
2019-11-27	Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2019 Nov 27;62(22):10108-10123.
2019-10	Discovery of clinical candidate DBPR112, a furanopyrimidine-based epidermal growth factor receptor inhibitor for the treatment of non-small cell lung cancer	Annals of Oncology. 2019 Oct;30(Suppl. 5):789.
2019-04-10	Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants	Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957.
2018-04	4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy	Bioorganic Chemistry. 2018 Apr;77:600-607.
2017-06	Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments	Journal of Virology. 2017 Jun;91(12):Article number e01836-16.
2017-01-13	Fused bicyclic pyrimidine compounds as aurora kinase inhibitors	IN279196/2017-01-13
2016-12	Phenyl benzenesulfonylhydrazides: Selective indoleamine 2,3-dioxygenase inhibitors with potent in vivo pharmacodynamic activity and antitumor efficacy	European Journal of Cancer. 2016 Dec;68(Suppl. 1):S83-S84.
2016-11-23	Fused bicyclic pyrimidine compounds as aurora kinase inhibitors	EP2276346/2016-11-23
2016-10-13	오로라 키나아제 저해제용 접합 2고리 피리미딘 화합물	KR10-1667822/2016-10-13
2016-06-07	Fused bicyclic pyrimidine compounds as aurora kinase inhibitors	CA2722220/2016-06-07
2016-04-12	Pyrazolylamine derivatives reveal the conformational switching between type I and type II binding modes of Anaplastic Lymphoma Kinase (ALK)	Journal of Medicinal Chemistry. 2016 Apr 12;59(8):3906-3919.
2016-01	Important hydrogen bond networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) inhibitor design revealed by crystal structures of imidazoleisoindole derivatives with IDO1	Journal of Medicinal Chemistry. 2016 Jan;59 (1):282-293.
2016-01	Phenyl benzenesulfonylhydrazides exhibit selective Indoleamine 2,3-Dioxygenase inhibition with potent in vivo pharmacodynamic activity and antitumor efficacy	Journal of Medicinal Chemistry. 2016 Jan;59(1):419-430.
2015-10	Identification of substituted naphthotriazolediones as novel tryptophan 2,3-dioxygenase (TDO) inhibitors through structure-based virtual screening	Journal of Medicinal Chemistry. 2015 Oct;58 (19):7807-7819.
2015-08-20	Fused bicyclic pyrimidine compounds as Aurora kinase inhibitors	AU2009241469/2015-08-20
2015-07-31	作為極光激酶抑制劑的稠合雙環嘧啶化合物	HK1151694/2015-07-31
2015-04-28	作為極光激酶抑制劑的稠合雙環嘧啶化合物	J/001653/2015-04-28
2014-10-29	作為極光激酶抑制劑的稠合雙環嘧啶化合物	ZL200980115577.4/2014-10-29
2014-10-29	作为极光激酶抑制剂的稠合双环嘧啶化合物	CN102014627/2014-10-29
2014-08	Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors	Bioorganic and Medicinal Chemistry Letters. 2014 Aug;24(15):3403-3406.

显示项目1-25 / 74. (共3页) 1 2 3 > >> 每页显示[10|25|50]项目